AEON AEON Biopharma, Inc.
$0.33▲ +12.72%
Healthcare
Other
After hours
$0.30▼ -6.85%
Sep 11, 7:59 PM ET
Volume 30.54M
Avg Volume (10D) 21.09M
Key Metrics & Fundamentals
Market Cap
$16.31M
P/E Ratio
–
Div Yield
–%
52W Range
0.18 - 1.45
% vs 50 MA
4.37%
% vs 200 MA
-59.06%
RSI-14
59.2
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.03
Free Cash Flow
-$3.70M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$10.65M
COGS
–
Operating Exp
$5.93M
Operating Income
-$5.93M
EBIT
-$5.93M
Pretax Income
-$1.16M
Net Income
-$1.16M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
Top Premarket Gainers
MT Newswires · Sep 10, 2026 11:10 AM
AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®
GlobeNewswire · Sep 9, 2026 12:00 PM
AEON Biopharma to Participate in Lake Street Capital Markets’ 10th Annual Best Ideas Growth (BIG10) Conference
GlobeNewswire · Aug 31, 2026 12:00 PM
AEON Biopharma Designates Former FDA Neuroscience Leader Paul Lee, M.D., Ph.D. as Acting Chief Regulatory Officer
GlobeNewswire · Aug 24, 2026 12:00 PM
AEON Reports Expanded Structural Data Supporting Molecular Similarity of ABP-450 to BOTOX®
GlobeNewswire · Aug 19, 2026 12:00 PM
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire · Aug 12, 2026 8:15 PM
AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards
GlobeNewswire · Aug 3, 2026 8:15 PM
Humana upgraded, Las Vegas Sands downgraded: Wall Street's top analyst calls
The Fly · Jul 30, 2026 1:38 PM
Aeon Biopharma Prices $13.8 Million Underwritten Public Offering
MT Newswires · Jul 14, 2026 1:22 PM
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding
GlobeNewswire · Jul 14, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See AEON's money flow as a full page
Social Sentiment
Avg +0.80 · 2 posts
DDNewsTradeWSB Fam - $AEON - Very Interesting Biotech Play - Cash per Share .72. Current PPS 1.00 - Catalyst only two weeks out.
r/wallstreetbets · Nov 5, 2025
The post highlights positive developments like FDA alignment and a key meeting, indicating strong bullish sentiment.
positive
+0.80
DDDiscussionPriceTarget$AEON (Aeon Biopharma's) → CL: $0.22 → 52wk-L: $0.16 / 52wk-H: $17.17 - If this get attention.....5-10X? 😄.
r/wallstreetbets · Jan 8, 2025
The author expresses a high potential return (5-10x) if the stock gains attention, using enthusiastic language and referencing the 52-week low.
very_positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.